09:48 AM EST - Revive Therapeutics Ltd. : Announced its results for the three months ended September 30. Cash and cash equivalents at September 30 totaled $1,790,469 (compared to $2,492,072 in the previous quarter). The net loss for the quarter was $912,799 ($398,588 in the prior-year quarter). Revive Therapeutics Ltd.
shares V.RVV are trading unchanged at $0.63.
